Approval of first interchangeable biosimilar insulin to increase competition with payer contracts: GlobalData Read more
Xeljanz receives marketing authorisation in EU to treat active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis Read more
Pfizer gets US FDA approval for PREVNAR 20, pneumococcal 20-valent conjugate vaccine for adults Read more
India, Pfizer discuss vaccine deal, seek to resolve dissension over vaccine indemnity: Report Read more